Sidebar? CTA!

Hello, CTA must CTA!

Addor Capital

Status

Active

Location

Nanjing, China

Total investments

226

Average round size

12M

Portfolio companies

206

Rounds per year

22.60

Lead investments

69

Follow on index

0.09

Exits

22

Areas of investment
AutomotiveBiotechnologySoftwareInformation TechnologyHealth CareManufacturingMedical DeviceMedicalSemiconductorElectronics

Summary

The venture was found in Asia in China. The main office of represented VC is situated in the Nanjing.

The real fund results show that this VC is 38 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2017. The fund is constantly included in 7-12 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.

The overall number of key employees were 1.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Huitongda, Chezhibao, Holaverse. Among the most successful fund investment fields, there are Supply Chain Management, Security. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Addor Capital, startups are often financed by Sequoia Capital China, FREES FUND, Sinovation Ventures. The meaningful sponsors for the fund in investment in the same round are Gobi Partners, Zhongguancun Bank, Zhengju Capital. In the next rounds fund is usually obtained by Tiantu Capital, Qihoo 360 Technology, PAG.

Show more

Investor highlights

Data2 CTA Block

Click click! Do this trick!

Investments analytics

Analytics

Total investments
226
Lead investments
69
Exits
22
Rounds per year
22.60
Follow on index
0.09
Investments by industry
  • Manufacturing (76)
  • Biotechnology (22)
  • Medical (22)
  • Health Care (19)
  • Electronics (17)
  • Show 157 more
Investments by region
  • China (219)
  • United States (2)
Peak activity year
2023
Number of Unicorns
2
Number of Decacorns
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
19M
Group Appearance index
0.59
Avg. company exit year
16
Avg. multiplicator
9.49
Strategy success index
0.20

Data1 Finished!

Buy stuff!

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Arthur Pharmaceuticals 04 Jun 2024 Early Stage Venture Zhejiang, Jiaxing, China
Renshuo Solar 18 Jan 2024 Manufacturing, Energy, Solar Early Stage Venture Jiangsu, Suzhou, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.